Ticagrelor

Ticagrelor ATC Code B01AC24 : Blood and blood forming organs - Antithrombotic agents - Antithrombotic agents - Platelet aggregation inhibitors excluding heparin - Ticagrelor
Ticagrelor
Ticagrelor
LatinTicagrelorum
RoutesOral
Pregnancy categoryC
FDA Approval Date2011-07-20
EMA Approval Date2010-12-03
Molecular FormulaC23H28F2N6O4S
Molecular Weight522.568026 g/mol
CAS Number274693-27-5
Ticagrelor 3D

Ticagrelor list of brand/trade names

  • United States: Brilinta
  • Germany: Brilique
  • France: Brilique
  • Spain: Brilique
  • Italy: Brilique
  • Canada: Brilinta
  • Russia: Brilinta
  • Australia: Brilinta
  • Netherlands: Brilique and Possia
  • Belgium: Brilique
  • Denmark: Brilique
  • Finland: Brilique
  • Greece: Brilique
  • Ireland: Brilique
  • Norway: Brilique
  • Portugal: Brilique
  • Sweden: Brilique
  • Switzerland: Brilique
  • Indonesia: Brilinta
  • Turkey: Brilinta


ATC Codes

  1. Alimentary tract and metabolisma
  2. Blood and blood forming organs
  3. Cardiovascular system
  4. Dermatological drugs
  5. Genitourinary system and reproductive hormones
  6. Systemic hormonal preparations
  7. Antiinfectives for systemic use
  8. Antineoplastic and immunomodulating agents
  9. Musculoskeletal system
  10. Nervous system
  11. Antiparasitic products, insecticides and repellents
  12. Respiratory system
  13. Sensory organs
  14. Various ATC structures

The newly added categories

  1. Givosiran
  2. Volanesorsen
  3. Casimersen
  4. Zanubrutinib
  5. Tivozanib
  6. Fedratinib
  7. Tucatinib
  8. Everolimus
  9. Abemaciclib
  10. Selumetinib